Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Fibrolamellar hepatocellular carcinoma

Other Names for this Disease
  • Eosinophilic glassy cell hepatoma
  • Eosinophilic hepatocellular carcinoma with lamellar fibrosis
  • Fibrolamellar carcinoma
  • Fibrolamellar oncocytic hepatoma
  • Fibrolamellar variant of hepatocellular carcinoma
More Names
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Fibrolamellar carcinoma is an uncommon malignant tumor that originates in the liver. This variant of hepatocellular carcinoma differs from conventional hepatocellular carcinoma in aetiology (cause), demographics, condition of the affected liver, and tumor markers.[1] This entity typically occurs in young adults (ages 20 to 40) with no underlying hepatitis or cirrhosis. In addition, the serum levels of alpha-fetoprotein are usually not elevated in patients with fibrolamellar hepatocellular carcinoma. Surgery is currently the most effective means of treating and controlling fibrolamellar variant cancer.[2] While there is some debate about the issue, fibrolamellar variant carcinoma may have a better outlook (prognosis) than other forms of liver cancer.[1][3]
Last updated: 10/28/2010


  1. Bhaijee F, Locketz ML, Krige JE. S Afr J Surg. 2009; Accessed 10/28/2010.
  2. What is Fibrolamellar?. Fibrolamellar Cancer Foundation. Accessed 10/28/2010.
  3. Liver Cancer Overview. American Cancer Society. 2010; Accessed 10/28/2010.
Your Questions Answered
by the Genetic and Rare Diseases Information Center

Please contact us with your questions about Fibrolamellar hepatocellular carcinoma. We will answer your question and update these pages with new resources and information.
On this page

In Depth Information

  • Medscape Reference provides information on this topic. Click on the link to view this information. You may need to register to view the medical textbook, but registration is free.
  • The Online Mendelian Inheritance in Man (OMIM) is an catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Fibrolamellar hepatocellular carcinoma. Click on the link to view a sample search on this topic.